CORTIDRO CREAM 20G 0.5%

CORTIDRO 0.5% CREMA

active ingredients

100 g of cream contain 0.5 g of Acetate Hydrocortisone Eccipients with known effects: cetostearilic alcohol, p-hydroxybenzoate methyl and p-hydroxybenzoate propile For the full list of excipients, see paragraph 6.1

Excellent

Cetostearilic alcohol, Laurilsulphate sodium, Vaseline oil, Yarn Vaseline, P-hydroxybenzoate methyl, P-hydroxybenzoate propile, Distilled water.

Therapeutic indications

The product is used in case of insect bites, itchings, erythema or burns, eczema.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients listed in paragraph 6.1. The use of hydrocortisone is contraindicated in the case of viral, bacterial or fungal diseases.

Population

For adults and children older than two years: apply on the part a minimum amount of cream and fry slightly in order to facilitate penetration. The application can be repeated two or three times a day for a few days. In case of non-response to therapy, please contact your doctor. Do not exceed the recommended dose.

Conservation

Do not store at temperature above 30°C.

Warnings

The cream does not find ophthalmological use or should be applied in the periocular areas. Avoid use in the treatment of itching if associated with vaginal losses. Avoid prolonged applications, especially on large surfaces. The use, especially if prolonged, of topical use products can give rise to phenomena of irritation or awareness. In this case it is necessary to stop the treatment and consult the doctor in order to establish suitable therapy. Visual disturbances With the use of systemic and topical corticosteroids, visual disturbances can be reported. If a patient occurs with symptoms such as blurred vision or other visual disorders, it is necessary to consider referral to an ophthalmologist for the evaluation of possible causes that may include cataracts, glaucoma or rare diseases such as central serum corioretinopathy (CSCR), which were reported after the use of systemic and topic corticosteroids. Pediatric population In children under two years, the product should be administered in cases of actual need under the direct control of the doctor.

Interactions

It is necessary to observe caution in the association of corticosteroids with amfotericin B because they can sum up their hypokalemic actions. Corticosteroids antagonize the effects of anticoagulants, therefore we do not recommend the contemporary use with the same especially if cumarinic derivatives. The barbiturates accelerate the metabolism of corticosteroids for enzymatic induction and reduce their effect, so we do not recommend their association.

Effects

Systemic side effects of topical corticosteroid preparations are extremely unlikely for the low doses used: in case of onset, stop therapy. Pathologies of the eye, not common (≥1/1.000, Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address www.agenziafarmaco.gov.it/content/come-segnalare-una-sospetta-reazione-avversa

Overdosing

Clinically unfavorable symptoms have not been detected at the indicated doses; in case of emergency the doctor intervenes according to the symptomatology detected.

The product should be administered in cases of actual need and under the direct control of the doctor.

Source: Farmadati